{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NRA@DH Gel", "ROS", "glioma", "inhibition of the PPP", "radiosensitization", "synergistic therapy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36820060", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S394377"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "18", "PubDate": {"Year": "2023"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Multifunctional Nano-Realgar Hydrogel for Enhanced Glioblastoma Synergistic Chemotherapy and Radiotherapy: A New Paradigm of an Old Drug.", "Pagination": {"StartPage": "743", "EndPage": "763", "MedlinePgn": "743-763"}, "Abstract": {"AbstractText": ["Realgar, as a kind of traditional mineral Chinese medicine, can inhibit multiple solid tumor growth and serve as an adjuvant drug in cancer therapy. However, the extremely low solubility and poor body absorptive capacity limit its application in clinical medicine. To overcome this therapeutic hurdle, realgar can here be fabricated into a nano-realgar hydrogel with enhanced chemotherapy and radiotherapy (RT) ability. Our objective is to evaluate the superior biocompatibility and anti-tumor activity of nano-realgar hydrogel.", "We have successfully synthesized nano-realgar quantum dots (QDs) coupling with 6-AN molecules (NRA QDs) and further encapsulated with a pH-sensitive dextran hydrogel carrier with hyaluronic acid coating (DEX-HA gel) to promote bioavailability, eventually forming a multifunctional nano-realgar hydrogel (NRA@DH Gel). To better investigate the tumor therapy efficiency of the NRA@DH Gel, we have established the mice in situ bearing GL261 brain glioblastoma as animal models assigned to receive intratumor injection of NRA@DH Gel.", "The designed NRA@DH Gel as an antitumor drug can not only exert the prominent chemotherapy effect but also as a \"sustainable reactive oxygen species (ROS) generator\" can inhibit in the pentose phosphate pathway (PPP) metabolism and reduce the production of nicotinamide adenine dinucleotide phosphate (NADPH), thereby inhibiting the conversion of glutathione disulfide (GSSG) to glutathione (GSH), reducing GSH concentrations in tumor cells, triggering the accumulation of ROS, and finally enhancing the effectiveness of RT.", "Through the synergistic effect of chemotherapy and RT, NRA@DH Gel effectively inhibited the proliferation and migration of tumor cells, suppressed tumor growth, improved motor coordination, and prolonged survival in tumor-bearing mice. Our work aims to improve the NRA@DH Gel-mediated synergistic chemotherapy and RT will endow a \"promising future\" for the old drug in clinically comprehensive applications."], "CopyrightInformation": "\u00a9 2023 Wang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}, {"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Wang", "ForeName": "Yihan", "Initials": "Y"}, {"Identifier": ["0000-0003-4977-363X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}, {"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Wei", "ForeName": "Yizhen", "Initials": "Y"}, {"Identifier": ["0000-0001-9583-577X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}, {"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Wu", "ForeName": "Yichun", "Initials": "Y"}, {"Identifier": ["0000-0003-4895-0315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}, {"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Zong", "ForeName": "Yue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Song", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": ["0000-0002-7247-0664"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Pu", "ForeName": "Shengyan", "Initials": "S"}, {"Identifier": ["0000-0001-9154-7412"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Wu", "ForeName": "Wenwen", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}], "LastName": "Zhou", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": ["0000-0002-9495-3405"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, People's Republic of China."}], "LastName": "Xie", "ForeName": "Jun", "Initials": "J"}, {"Identifier": ["0000-0002-4332-8773"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiotherapy Central Hospital, Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, 221009, People's Republic of China."}], "LastName": "Yin", "ForeName": "Haitao", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydrogels"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Glioblastoma"}, {"QualifierName": [], "DescriptorName": "Hydrogels"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "van Solinge TS, Nieland L, Chiocca EA, Broekman MLD. Advances in local therapy for glioblastoma \u2014 taking the fight to the tumour. Nat Rev Neurol. 2022;18(4):221\u2013236. doi:10.1038/s41582-022-00621-0", "ArticleIdList": ["10.1038/s41582-022-00621-0", "PMC10359969", "35277681"]}, {"Citation": "Madani F, Esnaashari SS, Webster TJ, Khosravani M, Adabi M. Polymeric nanoparticles for drug delivery in glioblastoma: state of the art and future perspectives. J Control Release. 2022;349:649\u2013661. doi:10.1016/j.jconrel.2022.07.023", "ArticleIdList": ["10.1016/j.jconrel.2022.07.023", "35878729"]}, {"Citation": "Madhavan K, Balakrishnan I, Lakshmanachetty S, et al. Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth. Clin Cancer Res. 2022;28(11):2409\u20132424. doi:10.1158/1078-0432.Ccr-21-4002", "ArticleIdList": ["10.1158/1078-0432.Ccr-21-4002", "35344040"]}, {"Citation": "van den Bent MJ, Tesileanu CMS, Wick W, et al. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, Phase 3 study. Lancet Oncology. 2021;22(6):813\u2013823. doi:10.1016/s1470-2045(21)00090-5", "ArticleIdList": ["10.1016/s1470-2045(21)00090-5", "PMC8191233", "34000245"]}, {"Citation": "Erel-Akbaba G, Carvalho LA, Tian T, et al. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. Acs Nano. 2019;13(4):4028\u20134040. doi:10.1021/acsnano.8b08177", "ArticleIdList": ["10.1021/acsnano.8b08177", "PMC7104714", "30916923"]}, {"Citation": "Zhang J, Chen Y, Fang J. Targeting thioredoxin reductase by micheliolide contributes to radiosensitizing and inducing apoptosis of HeLa cells. Free Radic Biol Med. 2022;186:99\u2013109. doi:10.1016/j.freeradbiomed.2022.05.007", "ArticleIdList": ["10.1016/j.freeradbiomed.2022.05.007", "35561844"]}, {"Citation": "Cheng K, Sano M, Jenkins CH, et al. Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures. ACS Nano. 2018;12(5):4946\u20134958. doi:10.1021/acsnano.8b02038", "ArticleIdList": ["10.1021/acsnano.8b02038", "29689158"]}, {"Citation": "Rey S, Schito L, Koritzinsky M, Wouters BG. Molecular targeting of hypoxia in radiotherapy. Adv Drug Deliv Rev. 2017;109:45\u201362. doi:10.1016/j.addr.2016.10.002", "ArticleIdList": ["10.1016/j.addr.2016.10.002", "27771366"]}, {"Citation": "Kaushik N, Kaushik NK, Choi EH, Kim JH. Blockade of Cellular Energy Metabolism through 6-Aminonicotinamide Reduces Proliferation of Non-Small Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress. Biology. 2021;10(11). doi:10.3390/biology10111088", "ArticleIdList": ["10.3390/biology10111088", "PMC8614681", "34827081"]}, {"Citation": "Sharma PK, Bhardwaj R, Dwarakanath BS, Varshney R. Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes. Cancer Lett. 2010;295(2):154\u2013166. doi:10.1016/j.canlet.2010.02.021", "ArticleIdList": ["10.1016/j.canlet.2010.02.021", "20363070"]}, {"Citation": "Varshney R, Adhikari JS, Dwarakanath BS. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line. Indian J Exp Biol. 2003;41(12):1384\u20131391.", "ArticleIdList": ["15320490"]}, {"Citation": "Koutcher JA, Alfieri AA, Matei C, Meyer KL, Street JC, Martin DS. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Magnetic resonance in medicine. 1996-Dec. 1996;36(6):887\u2013892. doi:10.1002/mrm.1910360611", "ArticleIdList": ["10.1002/mrm.1910360611", "8946354"]}, {"Citation": "Wen S, Ovais M, Li X, et al. Tailoring bismuth-based nanoparticles for enhanced radiosensitivity in cancer therapy. Nanoscale. 2022;14(23):8245\u20138254. doi:10.1039/d2nr01500e", "ArticleIdList": ["10.1039/d2nr01500e", "35647806"]}, {"Citation": "Zhou X, You M, Wang F, et al. Multifunctional Graphdiyne\u2013Cerium Oxide Nanozymes Facilitate MicroRNA Delivery and Attenuate Tumor Hypoxia for Highly Efficient Radiotherapy of Esophageal Cancer. Adv Mater. 2021;33(24):e2100556. doi:10.1002/adma.202100556", "ArticleIdList": ["10.1002/adma.202100556", "33949734"]}, {"Citation": "Bhardwaj P, Goda JS, Pai V, et al. Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platform. Nanoscale. 2021;13(40):17077\u201317092. doi:10.1039/d1nr04211d", "ArticleIdList": ["10.1039/d1nr04211d", "34622906"]}, {"Citation": "Zhang X-D, Luo Z, Chen J, et al. Ultrasmall Au 10\u221212 (SG) 10\u221212 Nanomolecules for High Tumor Specificity and Cancer Radiotherapy. Adv Mater. 2014;26(26):4565\u20134568. doi:10.1002/adma.201400866", "ArticleIdList": ["10.1002/adma.201400866", "24817169"]}, {"Citation": "Zhao J, Wang Y, Huang X, et al. Liu Shen Wan inhibits influenza virus-induced secondary Staphylococcus aureus infection in vivo and in vitro. J Ethnopharmacol. 2021;277:114066. doi:10.1016/j.jep.2021.114066", "ArticleIdList": ["10.1016/j.jep.2021.114066", "33766755"]}, {"Citation": "Ma W, Yue J, Liang S, et al. Realgar increases defenses against infection by Enterococcus faecalis in Caenorhabditis elegans. J Ethnopharmacol. 2021;268:113559. doi:10.1016/j.jep.2020.113559", "ArticleIdList": ["10.1016/j.jep.2020.113559", "33159994"]}, {"Citation": "Xu W, Chen Z, Shen X, Pi C. Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1. Iranian J Immunol Spr. 2019;16(2):170\u2013181. doi:10.22034/iji.2019.80260", "ArticleIdList": ["10.22034/iji.2019.80260", "31182691"]}, {"Citation": "Ma H, Kou J, Zhu D, Yan Y, Yu B. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis. Int Immunopharmacol. 2006;6(8):1355\u20131362. doi:10.1016/j.intimp.2006.03.003", "ArticleIdList": ["10.1016/j.intimp.2006.03.003", "16782549"]}, {"Citation": "Dagher T, Maslah N, Edmond V, et al. JAK2(V617F) myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML. J Exp Med. 2021;218:(2)e20201268. doi:10.1084/jem.20201268", "ArticleIdList": ["10.1084/jem.20201268", "PMC7579737", "33075130"]}, {"Citation": "Cui Z, Zhang Y, Xia K, et al. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors. Nat Commun. 2018;9(1):4347. doi:10.1038/s41467-018-06749-2", "ArticleIdList": ["10.1038/s41467-018-06749-2", "PMC6195623", "30341298"]}, {"Citation": "Kutny MA, Alonzo TA, Gerbing RB, et al. Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: report From the Children\u2019s Oncology Group Phase III Historically Controlled Trial AAML0631. J Clin Oncol. 2017;35(26):3021\u20133029. doi:10.1200/JCO.2016.71.6183", "ArticleIdList": ["10.1200/JCO.2016.71.6183", "PMC5590801", "28767288"]}, {"Citation": "Dilda PJ, Hogg PJ. Arsenical-based cancer drugs. Cancer Treat Rev. 2007;33(6):542\u2013564. doi:10.1016/j.ctrv.2007.05.001", "ArticleIdList": ["10.1016/j.ctrv.2007.05.001", "17624680"]}, {"Citation": "Wang T, Meng J, Wang C, et al. Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1alpha Downregulation. Front Oncol. 2019;9:333. doi:10.3389/fonc.2019.00333", "ArticleIdList": ["10.3389/fonc.2019.00333", "PMC6498897", "31106156"]}, {"Citation": "Zhu HH, Wu DP, Jin J, et al. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol. 2013;31(33):4215\u20134221. doi:10.1200/JCO.2013.48.8312", "ArticleIdList": ["10.1200/JCO.2013.48.8312", "24127444"]}, {"Citation": "Wang T, Zhang X, Jia M, et al. Hydrophilic Realgar Nanocrystals Prolong the Survival of Refractory Acute Myeloid Leukemia Mice Through Inducing Multi-Lineage Differentiation and Apoptosis. Int J Nanomedicine. 2022;17:2191\u20132202. doi:10.2147/IJN.S358469", "ArticleIdList": ["10.2147/IJN.S358469", "PMC9122054", "35599749"]}, {"Citation": "Wang S, Liu X, Wang S, et al. Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia. J Control Release. 2021;338:190\u2013200. doi:10.1016/j.jconrel.2021.08.035", "ArticleIdList": ["10.1016/j.jconrel.2021.08.035", "34428479"]}, {"Citation": "Cholujova D, Bujnakova Z, Dutkova E, et al. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. Br J Haematol. 2017;179(5):756\u2013771. doi:10.1111/bjh.14974", "ArticleIdList": ["10.1111/bjh.14974", "PMC5705577", "29048129"]}, {"Citation": "Tian Y, Wang X, Xi R, et al. Enhanced antitumor activity of realgar mediated by milling it to nanosize. Int J Nanomedicine. 2014;9:745\u2013757. doi:10.2147/IJN.S56391", "ArticleIdList": ["10.2147/IJN.S56391", "PMC3916444", "24516332"]}, {"Citation": "Shi D, Pu S, Yin H, et al. Fluorescent Realgar Nanoclusters for Nuclear Targeting-Triggered Tumor Theranostics. ACS Applied Nano Materials. 2022;5(5):6485\u20136499. doi:10.1021/acsanm.2c00577", "ArticleIdList": ["10.1021/acsanm.2c00577"]}, {"Citation": "Wu JZ, Chen G, Shao YB, et al. Fluorescent Realgar Quantum Dots: new Life for an Old Drug. Nano. 2016;11. doi:10.1142/s1793292016500053", "ArticleIdList": ["10.1142/s1793292016500053"]}, {"Citation": "Wang H, Liu Z, Gou Y, et al. Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway. Int J Nanomedicine. 2015;10:5505\u20135512. doi:10.2147/IJN.S83838", "ArticleIdList": ["10.2147/IJN.S83838", "PMC4560518", "26357474"]}, {"Citation": "Wang J, Loh KP, Wang Z, et al. Fluorescent nanogel of arsenic sulfide nanoclusters. Angew Chem Int Ed Engl. 2009;48(34):6282\u20136285. doi:10.1002/anie.200900586", "ArticleIdList": ["10.1002/anie.200900586", "19621402"]}, {"Citation": "Wang JZ, Lin M, Zhang TY, et al. Arsenic(II) sulfide quantum dots prepared by a wet process from its bulk. J Am Chem Soc. 2008;130(35):11596. doi:10.1021/ja804436w", "ArticleIdList": ["10.1021/ja804436w", "18693730"]}, {"Citation": "Zhang Y, Feng Z, Liu J, et al. Polarization of tumor-associated macrophages by TLR7/8 conjugated radiosensitive peptide hydrogel for overcoming tumor radioresistance. Bioactive Materials. 2022;16:359\u2013371. doi:10.1016/j.bioactmat.2021.12.033", "ArticleIdList": ["10.1016/j.bioactmat.2021.12.033", "PMC8965723", "35386314"]}, {"Citation": "Luo FQ, Xu W, Zhang JY, et al. An Injectable Nanocomposite Hydrogel Improves Tumor Penetration and Cancer Treatment Efficacy. Acta Biomater. 2022;147:235\u2013244. doi:10.1016/j.actbio.2022.05.042", "ArticleIdList": ["10.1016/j.actbio.2022.05.042", "35644327"]}, {"Citation": "Hivare P, Gangrade A, Swarup G, et al. Peptide functionalized DNA hydrogel enhances neuroblastoma cell growth and differentiation. Nanoscale. 2022;14(24):8611\u20138620. doi:10.1039/d1nr07187d", "ArticleIdList": ["10.1039/d1nr07187d", "35687044"]}, {"Citation": "Wen Y, Liu Y, Zhang H, et al. A responsive porous hydrogel particle-based delivery system for oncotherapy. Nanoscale. 2019;11(6):2687\u20132693. doi:10.1039/c8nr09990a", "ArticleIdList": ["10.1039/c8nr09990a", "30693935"]}, {"Citation": "Zhang W, Shi Y, Li H, et al. In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation. Carbohydr Polym. 2022:288119418. doi:10.1016/j.carbpol.2022.119418", "ArticleIdList": ["10.1016/j.carbpol.2022.119418", "35450661"]}, {"Citation": "Wu S, Yang Y, Wang S, et al. Dextran and peptide-based pH-sensitive hydrogel boosts healing process in multidrug-resistant bacteria-infected wounds. Carbohydr Polym. 2022;278:118994. doi:10.1016/j.carbpol.2021.118994", "ArticleIdList": ["10.1016/j.carbpol.2021.118994", "34973798"]}, {"Citation": "Zhang M, Chen G, Lei M, Lei J, Li D, Zheng H. A pH-sensitive oxidized-dextran based double drug-loaded hydrogel with high antibacterial properties. Int J Biol Macromol. 2021;182:385\u2013393. doi:10.1016/j.ijbiomac.2021.03.169", "ArticleIdList": ["10.1016/j.ijbiomac.2021.03.169", "33798586"]}, {"Citation": "Zhang X, Zhang T, Ma X, et al. The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy. Asian J Pharm Sci. 2020;15(5):605\u2013616. doi:10.1016/j.ajps.2019.10.001", "ArticleIdList": ["10.1016/j.ajps.2019.10.001", "PMC7610203", "33193863"]}, {"Citation": "Chatterjee S, Hui PC, Wat E, Kan CW, Leung PC, Wang W. Drug delivery system of dual-responsive PF127 hydrogel with polysaccharide-based nano-conjugate for textile-based transdermal therapy. Carbohydr Polym. 2020;236:116074. doi:10.1016/j.carbpol.2020.116074", "ArticleIdList": ["10.1016/j.carbpol.2020.116074", "32172887"]}, {"Citation": "Qu J, Zhao X, Ma PX, Guo B. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Acta Biomater. 2017;58:168\u2013180. doi:10.1016/j.actbio.2017.06.001", "ArticleIdList": ["10.1016/j.actbio.2017.06.001", "28583902"]}, {"Citation": "Liu T, Sun L, Zhang Y, Wang Y, Zheng J. Imbalanced GSH/ROS and sequential cell death. J Biochem Mol Toxicol. 2022;36(1):e22942. doi:10.1002/jbt.22942", "ArticleIdList": ["10.1002/jbt.22942", "34725879"]}, {"Citation": "Zheng CY, Lam SK, Li YY, Ho JC. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Int J Oncol. 2015;46(3):1067\u20131078. doi:10.3892/ijo.2015.2826", "ArticleIdList": ["10.3892/ijo.2015.2826", "25572414"]}, {"Citation": "Hou Y, Jin J, Duan H, et al. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer. Biomaterials. 2022;283:121440. doi:10.1016/j.biomaterials.2022.121440", "ArticleIdList": ["10.1016/j.biomaterials.2022.121440", "35245731"]}, {"Citation": "Yang Z, Luo H, Cao Z, et al. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer. Nanoscale. 2016;8(22):11543\u201311558. doi:10.1039/c6nr01749e", "ArticleIdList": ["10.1039/c6nr01749e", "27203688"]}, {"Citation": "Xue X, You S, Zhang Q, et al. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. Mol Pharm. 2012;9(3):634\u2013644. doi:10.1021/mp200571k", "ArticleIdList": ["10.1021/mp200571k", "PMC3310394", "22289032"]}, {"Citation": "Yong Y, Zhang C, Gu Z, et al. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response. ACS Nano. 2017;11(7):7164\u20137176. doi:10.1021/acsnano.7b03037", "ArticleIdList": ["10.1021/acsnano.7b03037", "28640996"]}, {"Citation": "Robillard L, Liao M, Minh N, Harding TC, Simmons AD, Dusek RL. The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models. J Immunother. 2022;45(8):335\u2013348. doi:10.1097/cji.0000000000000427", "ArticleIdList": ["10.1097/cji.0000000000000427", "35791438"]}, {"Citation": "Dowsett M, Nielsen TO, A\u2019Hern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011;103(22):1656\u20131664. doi:10.1093/jnci/djr393", "ArticleIdList": ["10.1093/jnci/djr393", "PMC3216967", "21960707"]}, {"Citation": "Yang L, Friedland S, Corson N, Xu L. GPR56 Inhibits Melanoma Growth by Internalizing and Degrading Its Ligand TG2. Cancer Res. 2014;74(4):1022\u20131031. doi:10.1158/0008-5472.Can-13-1268", "ArticleIdList": ["10.1158/0008-5472.Can-13-1268", "PMC3944670", "24356421"]}, {"Citation": "Li X, Zhao S, Fu Y, et al. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2. Int J Biol Sci. 2021;17(15):4327\u20134339. doi:10.7150/ijbs.64851", "ArticleIdList": ["10.7150/ijbs.64851", "PMC8579463", "34803501"]}, {"Citation": "Bellinzona M, Roser F, Matthies C, Samii M, Saini M. Biopolymer-mediated suramin chemotherapy in the treatment of experimental brain tumours. Acta Oncol. 2004;43(3):259\u2013263. doi:10.1080/02841860310023129", "ArticleIdList": ["10.1080/02841860310023129", "15244249"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "1"}, {"Year": "2023", "Month": "2", "Day": "2"}, {"Year": "2023", "Month": "2", "Day": "23", "Hour": "10", "Minute": "31"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["36820060", "PMC9938708", "10.2147/IJN.S394377", "394377"]}}], "PubmedBookArticle": []}